CTNNB1 and adrenal cortex carcinoma: Other notable gene mutations besides those mentioned above included BRAF and CTNNB1. BRAF alterations was detected in 15.9% of ACC patients, being significantly higher than that of PDAC (1.7%, p < 0.001).